# Xavier Martinez

Лучшие выпуски подкастов
Обновлено:

What’s News in Markets: Campbell’s Snack Problem, Centene Sinks, Petco Optimism

Why are salty snacks hurting Campbell’s shares? And what’s ailing Centene stock? Plus, why Petco thinks it can make a profit comeback? Host Xavier Martinez discusses the biggest stock moves of the week and the news that drove them. Sign up for the WSJ's free Markets A.M. newsletter. Hosted by Sim…

Health Officials Trying to Trace and Contain Deadly Hantavirus Outbreak

P.M. Edition for May 6. A patient in Switzerland has been hospitalized with a strain of hantavirus after returning from a cruise to South America. Three people who traveled on that cruise ship have died. Journal reporter Xavier Martinez discusses what’s concerning about the virus and what health of…

Health Officials Trying to Trace and Contain Deadly Hantavirus Outbreak

P.M. Edition for May 6. A patient in Switzerland has been hospitalized with a strain of hantavirus after returning from a cruise to South America. Three people who traveled on that cruise ship have died. Journal reporter Xavier Martinez discusses what’s concerning about the virus and what health of…

A New Generation of Drugs Could Lower Heart Attack Risk for Millions

P.M. Edition for May 27. Pharmaceutical companies have been testing a new type of drug to lower levels of lipoprotein(a); high levels have been linked to heart disease and can’t be lowered with diet and exercise. WSJ reporter Xavier Martinez walks us through how the new drugs work and what is still…

A New Generation of Drugs Could Lower Heart Attack Risk for Millions

P.M. Edition for May 27. Pharmaceutical companies have been testing a new type of drug to lower levels of lipoprotein(a); high levels have been linked to heart disease and can’t be lowered with diet and exercise. WSJ reporter Xavier Martinez walks us through how the new drugs work and what is still…

Pound for Pound best boxer in Sacramento

Xavier Martinez 15-0 (11 Kos) professional boxer signed to Floyd Mayweathers, TMT promotions. The first big tournament he won was the Jr. Golden Gloves in 2010 and after that he went to nationals in 2012 and 2013 and finished ranked #4 & #3 respectively. He finished his amateur career with a recor…

The personalized vaccine that could revolutionize cancer treatment

Merck and Moderna have announced that a new mRNA vaccine has succeeded in blocking the return of one of the deadliest cancers. Wall Street Journal reporter Xavier Martinez explains more about the trial and why its giving cancer researchers hope.Then, primaries are underway, and in many races, progr…

From COVID To Cancer: How Far Can Moderna Take mRNA Technology?

Xavier Martinez, News Associate at The Wall Street Journal, breaks down Moderna’s mRNA ambitions, its pipeline beyond COVID-19 and the challenges ahead.

Meta Reaches $18 Billion Settlement Over Claims It Harmed Teens

P.M. Edition for Aug. 26. Tech reporter Meghan Bobrowsky tells us why the Meta settlement could change how teenagers use some of the world’s most popular apps. Plus, the FDA approves a milestone therapy for pancreatic cancer. WSJ reporter Xavier Martinez discusses how the nearly $40,000-a-month dru…

The Cancer Vaccine That Could Save Moderna

For years, Moderna was a one-hit wonder, a company that bet everything on mRNA, struck gold with a COVID vaccine and then watched its stock crater as the pandemic faded. Now, the company may have found a way to fight skin cancer. An experimental mRNA-based vaccine succeeded in preventing melanoma f…